HIGHLIGHTS
- who: Yeli Li and collaborators from the Department of Pharmacy, Macau University of Science and Technology, Macau, China have published the research work: Icariside II, a Naturally Occurring SIRT3 Agonist, Protects against Myocardial Infarction through the AMPK/PGC-1/Apoptosis Signaling Pathway, in the Journal: Antioxidants 2022, 11, x FOR PEER REVIEW of /2022/
- what: This study was designed to investigate the effect and possible underlying mechanism of ICS on MI both in vivo and in vitro. 99ofof1818 3.5.ICS ICSIIIIProtected Protectedagainst againstOGD-Induced OGD-InducedCardiomyocyte CardiomyocyteInjury Injury 3.5. further confirm of ICS . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.